44
Participants
Start Date
October 1, 2020
Primary Completion Date
January 4, 2025
Study Completion Date
January 27, 2025
Urokinase
In the higher dose group: 30,000unit (1.5ml) per catheter lumen is instilled per catheter lumen (in both arterial and venous ports respectively). This allows utilization of the entire vial of Urokinase to prevent wastage and to assess if this increase in dose improves catheter patency and survival, thus reducing the need for a TDC exchange in our HD patients. The urokinase lock is dwelled for at least 2 hours, after which aspiration and catheter testing will be done by a trained HD nurse.
Urokinase
20,000unit (1ml) is instilled per catheter lumen (in both arterial and venous ports respectively); and the remaining 1ml is discarded.
Khoo Teck Puat Hospital, Singapore
Lead Sponsor
National Healthcare Group, Singapore
OTHER_GOV